炎症反应驱动乳腺癌转移的研究进展

doi:10.11904/j.issn.1002-3070.2024.05.009

摘要/Abstract

摘要： 乳腺癌治疗面临的最大挑战是转移和耐药,乳腺癌转移增加患者死亡风险并降低生存质量。目前乳腺癌的转移机制尚未完全明确,转移的多步骤过程即转移级联,是由肿瘤细胞的内在特性和肿瘤微环境共同决定的。在驱动乳腺癌转移的因素中,炎症反应的作用逐渐受到重视。由免疫细胞、细胞因子、趋化因子和生长因子组成的炎症环境对癌细胞的侵袭和转移有重要影响。通过研究炎症反应与肿瘤细胞及肿瘤微环境之间的相互作用,有望发现预防和治疗乳腺癌转移的药物靶点。本文就炎症反应在乳腺癌转移肿瘤微环境中的作用进行综述。

关键词: 乳腺癌, 炎症反应, 转移

Abstract: The biggest challenge of breast cancer treatment is metastasis and drug resistance.Breast cancer metastasis increases mortality and decreases the life quality of patients.At present,the mechanism of breast cancer metastasis is not completely understood,and the multi-step process of metastasis,namely metastasis cascade,is determined by the internal characteristics of tumor cells and tumor microenvironment.Among the factors driving breast cancer metastasis,the role of inflammatory reaction has gradually attracted attention.The inflammatory environment composed of immune cells,cytokines,chemokines,and growth factors has an important impact on the invasion and metastasis of cancer cells.By studying the interaction between inflammatory reaction,tumor cells and tumor microenvironment,it is expected to discover drug targets for the prevention and treatment of breast cancer metastasis.This article reviews the role of inflammation in the tumor microenvironment of breast cancer metastasis.

Key words: Breast cancer, Inflammatory response, Metastasis

中图分类号:

R737.9

刘冬, 张太娟, 党计锋. 炎症反应驱动乳腺癌转移的研究进展[J]. 实用肿瘤学杂志, 2024, 38(5): 336-341.

LIU Dong, ZHANG Taijuan, DANG Jifeng. The research progress of inflammatory reaction driving breast cancer metastasis[J]. Journal of Practical Oncology, 2024, 38(5): 336-341.

参考文献

1 Siegel RL,Miller KD,Fuchs HE,et al.Cancer statistics,2022[J].CA Cancer J Clin,2022,72(1):7-33.
2 Chaffer CL,Weinberg RA.A perspective on cancer cell metastasis[J].Science,2011,331(6024):1559-1564.
3 Ben-Baruch A.Host microenvironment in breast cancer development:inflammatory cells,cytokines and chemokines in breast cancer progression:reciprocal tumor-microenvironment interactions[J].Breast Cancer Res,2003,5(1):31-36.
4 Balkwill F,Mantovani A.Inflammation and cancer:back to virchow?[J].Lancet,2001,357(9255):539-545.
5 Shacter E,Weitzman SA.Chronic inflammation and cancer[J].Oncology(Williston Park),2002,16(2):217-226.
6 Hibino S,Kawazoe T,Kasahara H,et al.Inflammation-induced tumorigenesis and metastasis[J].Int J Mol Sci,2021,22(11):5421.
7 Danforth DN.The role of chronic inflammation in the development of breast cancer[J].Cancers(Basel),2021,13(15):3918.
8 Zhang Y,Song M,Yang Z,et al.Healthy lifestyles,systemic inflammation and breast cancer risk:a mediation analysis[J]BMC Cancer,2024,24(1):208.
9 Wei C,Ai H,Mo D,et al.A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients[J].Front Endocrinol(Lausanne),2024,15:1388861.
10 Wang H,Yung MMH,Ngan HYS,et al.The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression[J].Int J Mol Sci,2021,22(12):6560.
11 Liu W,Luo G.NEDD9 is transcriptionally regulated by HDAC4 and promotes breast cancer metastasis and macrophage M2 polarization via the FAK/NF-κB signaling pathway[J].Neoplasia,2024,57:101059.
12 Zhang Y,Zheng A,Shi Y,et al.SNORA5A regulates tumor-associated macrophage M1/M2 phenotypes via TRAF3IP3 in breast cancer[J].Braz J Med Biol Res,2024,8(57):e13809.
13 Demkow U.Neutrophil extracellular traps(NETs)in cancer invasion,evasion and metastasis[J].Cancers(Basel),2021,13(17):4495.
14 Xiong S,Dong L,Cheng L.Neutrophils in cancer carcinogenesis and metastasis[J].J Hematol Oncol,2021,14(1):173.
15 Danforth DN.The role of chronic inflammation in the development of breast cancer[J].Cancers(Basel),2021,13(15):3918.
16 Monteran L,Erez N.The dark side of fibroblasts:cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment[J].Front Immunol,2019,10:1835.
17 Diep CH,Spartz A,Truong TH,et al.Progesterone receptor signaling promotes cancer associated fibroblast mediated tumorigenicity in ER+ breast cancer[J].Endocrinology,2024,165(9):92.
18 Wen S,Hou Y,Fu L,et al.Cancer-associated fibroblast(CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling[J].Cancer Lett,2019,442:320-332.
19 Xu Y,Mao Y,Lv Y,et al.B cells in tumor metastasis:friend or foe?[J].Int J Biol Sci,2023,19(8):2382-2393.
20 Lam BM,Verrill C.Clinical significance of tumour-infiltrating B lymphocytes(TIL-Bs)in breast cancer:a systematic literature review[J].Cancers(Basel),2023,15(4):1164.
21 Ramos MJ,Lui AJ,Hollern DP.The evolving landscape of B cells in cancer metastasis[J].Cancer Res,2023,83(23):3835-3845.
22 Zhang Y,Morgan R,Chen C,et al.Mammary-tumor-educated B cells acquire LAP/TGF-beta and PD-L1 expression and suppress anti-tumor immune responses[J].Int Immunol,2016,28(9):423-433.
23 Zgura A,Galesa L,Bratila E,et al.Relationship between tumor infiltrating lymphocytes and progression in breast cancer[J].Maedica,2018,13(4):317-320.
24 Ciarka A,PiAątek M,Pęksa R,et al.Tumor-infiltrating lymphocytes(TILs)in breast cancer:prognostic and predictive significance across molecular subtypes[J].Biomedicines,2024,12(4):763.
25 Zareinejad M,Mehdipour F,Roshan-Zamir M,et al.Dual functions of T lymphocytes in breast carcinoma:from immune protection to orchestrating tumor progression and metastasis[J].Cancers(Basel),2023,15(19):4771.
26 Ruocco MR,Gisonna A,Acampora V,et al.Guardians and mediators of metastasis:exploring T lymphocytes,myeloid-derived suppressor cells,and tumor-associated macrophages in the breast cancer microenvironment[J].Int J Mol Sci,2024,25(11):6224.
27 Delprat V,Huart C,Feron O,et al.The impact of macrophages on endothelial cells is potentiated by cycling hypoxia:enhanced tumor inflammation and metastasis[J].Front Oncol,2022,12:961753.
28 Li QQ,Guo M,He GH,et al.VEGF-induced Nrdp1 deficiency in vascular endothelial cells promotes cancer metastasis by degrading vascular basement membrane[J].Oncogene,2024,43(24):1836-1851.
29 Galloni C,Egnuni T,Zahed Mohajerani S,et al.Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling[J].Commun Biol,2024,7(1):602.
30 Koning T,Cordova F,Aguilar G,et al.S-nitrosylation in endothelial cells contributes to tumor cell adhesion and extravasation during breast cancer metastasis[J].Biol Res,2023,56(1):51.
31 Benedicto A,Herrero A,Romayor I,et al.Liver sinusoidal endothelial cell ICAM-1 mediated tumor/endothelial crosstalk drives the development of liver metastasis by initiating inflammatory and angiogenic responses[J].Sci Rep,2019,9(1):13111.
32 Wettschureck N,Strilic B,Offermanns S.Passing the vascular barrier:endothelial signaling processes controlling extravasation[J].Physiol Rev,2019,99(3):1467-1525.
33 Manfioletti G,Fedele M.Epithelial-mesenchymal transition(EMT)2021[J].Int J Mol Sci,2022,23(10):5848.
34 Yu M,Bardia A,Wittner BS,et al.Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition[J].Science,2013,339(6119):580-584.
35 Park M,Kim D,Ko S,et al.Breast cancer metastasis:mechanisms and therapeutic implications[J].Int J Mol Sci,2022,23(12):6806.
36 Cohen EN,Gao H,Anfossi S,et al.Inflammation mediated metastasis:immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells[J].PLoS One,2015,10(7):e0132710.
37 Dai Y,Zhang X,Ou Y,et al.Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment[J].Cell Commun Signal,2023,21(1):190.
38 Siersbaek R,Scabia V,Nagarajan S,et al.IL6/STAT3 signaling hijacks estrogen receptor alpha enhancers to drive breast cancer metastasi[J].Cancer Cell,2020,38:412-423.
39 Wu Q,Luo Y,Lin N,et al.Prognostic value and immune signatures of anoikis-related genes in breast cancer[J].J Immunother,2024,47(8):328-341.
40 Marozzi M,Parnigoni A,Negri A,et al.Inflammation,extracellular matrix remodeling,and proteostasis in tumor microenvironment[J].Int J Mol Sci,2021,22(15):8102.
41 Winkler J,Abisoye-Ogunniyan A,Metcalf KJ,et al.Concepts of extracellular matrix remodelling in tumour progression and metastasis[J].Nat Commun,2020,11(1):5120.
42 Avalle L,Raggi L,Monteleone E,et al.STAT3 induces breast cancer growth via ANGPTL4,MMP13 and STC1 secretion by cancer associated fibroblasts[J].Oncogene,2022,41(10):1456-1467.
43 Li R,Wen A,Lin J.Pro-inflammatory cytokines in the formation of the pre-metastatic niche[J].Cancers,2020,12(12):3752.
44 Deguchi A,Maru Y.Inflammation-associated premetastatic niche formation[J].Inflamm Regen,2022,42(1):22.
45 Rosenbaum SR,Hughes CJ,Fields KM,et al.An EYA3/NF-κB/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasis[J].bioRxiv,2024[Preprint].
46 Deyell M,Garris CS,Laughney AM.Cancer metastasis as a non-healing wound[J].Br J Cancer,2021,124(9):1491-1502.
47 Gomatou G,Syrigos N,Vathiotis IA,et al.Tumor dormancy:implications for invasion and metastasis[J].Int J Mol Sci,2021,22(9):4862.

[1]	张宇晴, 荆晶, 刘兆良, 安静, 安巍巍. MZB1的可变剪接事件是乳腺癌内分泌治疗耐药的潜在生物标志物[J]. 实用肿瘤学杂志, 2024, 38(5): 313-322.
[2]	杨闽叶, 鲜童丞, 刘景建, 别俊, 王杰, 罗义. IL-23在乳腺癌组织中的表达及其与患者临床病理特征的相关性[J]. 实用肿瘤学杂志, 2024, 38(5): 323-329.
[3]	李倩妮, 徐灵燕, 李健, 姚雪佩, 刘美娜. 乳腺癌多维治疗质量纵向评价的趋势分析[J]. 实用肿瘤学杂志, 2024, 38(4): 213-220.
[4]	高光强, 王发琳, 李娟, 田虹, 果思伽, 于晓兰, 杨婷婷, 刘家仁. β-紫罗兰酮通过NF-κB途径抑制乳腺癌细胞增殖[J]. 实用肿瘤学杂志, 2024, 38(4): 254-261.
[5]	邵禹铭, 朱坤兵, 张洁. SP/NK-1R系统在乳腺癌中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(4): 268-272.
[6]	殷海燕, 淳志明, 马巧君, 成涵, 丁高恒, 张海燕, 刘玉琴. 2019年甘肃省肿瘤登记地区女性乳腺癌流行特征及2010-2019年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(3): 141-148.
[7]	黑龙江省医学会乳腺肿瘤学组. 黑龙江省乳腺癌HER2低表达临床病理诊断专家共识(2024版)[J]. 实用肿瘤学杂志, 2024, 38(2): 71-78.
[8]	孟凡岗, 陈飞, 甄立军. DLX2对乳腺癌细胞增殖、迁移、侵袭、凋亡及乳腺癌干细胞特性的影响[J]. 实用肿瘤学杂志, 2024, 38(2): 88-95.
[9]	郑鹏飞, 董良鹏, 高延鑫, 张一夫, 秦双. 白细胞介素-38对乳腺癌患者CD8⁺T淋巴细胞功能的影响[J]. 实用肿瘤学杂志, 2024, 38(1): 30-36.
[10]	谢俊岭. 活化白细胞黏附分子在乳腺癌中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(1): 45-49.
[11]	冯楚然, 曹剑钊, 陈子印, 张大昕, 鲁海玲. 乳腺癌放射性心脏损伤及其预防措施的研究进展[J]. 实用肿瘤学杂志, 2023, 37(6): 513-518.
[12]	庞武, 陈莉江, 朱宇, 吴涯昆, 张伟. 血清miRNA-24和miRNA-509在肝细胞癌患者血清中的表达及与预后的关系[J]. 实用肿瘤学杂志, 2023, 37(5): 411-415.
[13]	赵诗璐, 庞达. 乳腺癌预后相关基因的生物信息学筛选与分析[J]. 实用肿瘤学杂志, 2023, 37(5): 422-428.
[14]	初思彤, 许庆勇. 三阴性乳腺癌免疫治疗耐药机制的研究进展[J]. 实用肿瘤学杂志, 2023, 37(5): 449-453.
[15]	王新萍, 张自云, 王学东. 非编码RNA在乳腺癌化疗耐药中作用的研究进展[J]. 实用肿瘤学杂志, 2023, 37(5): 454-458.